NovaBridge Biosciences (NBP) Ownership
NBP ownership summary
as of October 18, 2026- Institutions
- 34.2% of shares outstanding
- Insiders
- 14.28% of shares outstanding
- Shares outstanding
- 116.0M
- Float
- 64.4M shares available to trade
- Short interest
- 6.27% 3.3M shares short
- Days to cover
- 5.62 short interest down 12.4% vs prior month
- Institutions 34.23%
- Insiders 14.28%
- Other investors 51.49%
NBP top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | HHG PLC | 5.20% | 6.0M | $7.6M | −2.4M (−28.5%) | March 31, 2026 |
| 2 | Hillhouse Capital Advisors, Ltd. | 5.16% | 6.0M | $7.5M | — | June 30, 2026 |
| 3 | Morgan Stanley - Brokerage Accounts | 3.15% | 3.7M | $4.6M | −184,970 (−4.8%) | June 30, 2026 |
| 4 | AIHC Capital Management Limited | 2.48% | 2.9M | $3.6M | +615,100 (+27.2%) | June 30, 2026 |
| 5 | Siren, L.L.C. | 1.73% | 2.0M | $2.5M | −995,261 (−33.2%) | June 30, 2026 |
| 6 | Marshall Wace Asset Management Ltd | 1.06% | 1.2M | $1.6M | +1.2M (0.0%) | June 30, 2026 |
| 7 | Candriam Luxembourg S.C.A. | 0.98% | 1.1M | $1.4M | — | June 30, 2026 |
| 8 | Adage Capital Partners Gp LLC | 0.86% | 1.0M | $1.3M | — | June 30, 2026 |
| 9 | Two Sigma Investments LLC | 0.73% | 851K | $1.1M | +851,348 (0.0%) | June 30, 2026 |
| 10 | Renaissance Technologies Corp | 0.65% | 758K | $955,365 | +485,814 (+178.3%) | June 30, 2026 |
| 11 | BlackRock Inc | 0.59% | 686K | $864,622 | +58,712 (+9.4%) | June 30, 2026 |
| 12 | Citadel Advisors Llc | 0.54% | 623K | $784,767 | +456,215 (+273.8%) | June 30, 2026 |
| 13 | E Fund Management Co., Ltd. | 0.51% | 589K | $742,165 | +589,020 (0.0%) | June 30, 2026 |
| 14 | Exome Asset Management LLC | 0.50% | 577K | $726,970 | — | June 30, 2026 |
| 15 | State Street Corp | 0.31% | 360K | $454,074 | −9,731 (−2.6%) | June 30, 2026 |
| 16 | Woodline Partners LP | 0.30% | 350K | $441,000 | −350,000 (−50.0%) | June 30, 2026 |
| 17 | Fiera Capital Corporation | 0.27% | 316K | $397,758 | — | June 30, 2026 |
| 18 | UBS Group AG | 0.26% | 302K | $380,243 | +238,239 (+374.9%) | June 30, 2026 |
| 19 | Barclays PLC | 0.24% | 279K | $351,564 | −20,280 (−6.8%) | June 30, 2026 |
| 20 | TAIKANG ASSET MANAGEMENT (HONG KONG) CO LTD | 0.15% | 171K | $215,373 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 4.5M shares and 6 cut 4.0M.
NBP top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Belfius Equities Cure C Cap | 0.98% | 1.1M | $1.4M | — | March 31, 2026 |
| 2 | iShares Biotechnology ETF | 0.56% | 653K | $823,134 | −4,952 (−0.8%) | September 30, 2026 |
| 3 | E Fund Global Medi Inds Allc QDII CNY A | 0.51% | 589K | $742,165 | −441,851 (−42.9%) | June 30, 2026 |
| 4 | OAKS Emerg and Frntr Opp A EUR Acc Ser 4 | 0.27% | 316K | $397,606 | −121 (−0.0%) | June 30, 2026 |
| 5 | State Street® SPDR® Portfolio EM ETF | 0.26% | 298K | $375,399 | — | September 30, 2026 |
| 6 | ALPS Medical Breakthroughs ETF | 0.13% | 150K | $189,210 | — | September 30, 2026 |
| 7 | Taikang Kaitai China New Opp I HKD Acc | 0.11% | 129K | $162,244 | +128,765 (0.0%) | December 31, 2025 |
| 8 | iShares Nasdaq US Biotech ETF USD Acc | 0.08% | 96K | $120,961 | +832 (+0.9%) | September 30, 2026 |
| 9 | Invesco NASDAQ Future Gen 200 ETF | 0.06% | 66K | $82,982 | — | September 30, 2026 |
| 10 | Fidelity Nasdaq Composite Index | 0.04% | 44K | $55,596 | −24,725 (−35.9%) | August 31, 2026 |
| 11 | China Universal NASDAQ Bio-Tch ETF(QDII) | 0.02% | 18K | $22,509 | +924 (+5.5%) | June 30, 2026 |
| 12 | State Street® SPDR® S&P® China ETF | 0.01% | 15K | $18,751 | — | September 30, 2026 |
| 13 | DFA Emerging Markets Core Equity 2 I | 0.01% | 13K | $15,857 | −7,450 (−37.2%) | August 31, 2026 |
| 14 | Dimensional World Equity GBP Acc | 0.01% | 11K | $13,886 | — | August 31, 2026 |
| 15 | Dimensional World Allc 60/40 GBP Acc | 0.01% | 9,338 | $11,766 | — | August 31, 2026 |
| 16 | DFA Emerging Markets Social Core Port | 0.01% | 8,887 | $11,198 | −6,243 (−41.3%) | August 31, 2026 |
| 17 | Invesco Nasdaq Biotechnology ETF | 0.01% | 7,872 | $9,919 | +364 (+4.8%) | September 30, 2026 |
| 18 | ProShares Ultra Nasdaq Biotechnology | <0.01% | 3,890 | $4,901 | — | September 30, 2026 |
| 19 | GF NASDAQ Bio-Tech Idx QDII USD A | <0.01% | 2,377 | $2,995 | +335 (+16.4%) | June 30, 2026 |
| 20 | Dimensional EM Cor Eq LC ESG Sc USD A | <0.01% | 1,400 | $1,764 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NBP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NBP
Institutional investors own 34.2% of NovaBridge Biosciences's shares and insiders 14.28%. The largest holder is HHG PLC with 5.20% of the shares (6.0M), as of March 31, 2026. Among the top 20 institutions, 8 added shares and 6 reduced their stake in the latest filings. Short interest is 6.27% of the float, or 5.62 days of average trading volume. The share count rose 356.2% since 2018.
Related: NBP analyst forecast, NBP key metrics. See the NBP stock overview for the latest quote and news.
NBP ownership FAQ
Who owns the most NovaBridge Biosciences stock?
The largest shareholders of NovaBridge Biosciences are HHG PLC (5.20%), Hillhouse Capital Advisors, Ltd. (5.16%), Morgan Stanley - Brokerage Accounts (3.15%), AIHC Capital Management Limited (2.48%), Siren, L.L.C. (1.73%).
What percentage of NovaBridge Biosciences is owned by institutions?
Institutions hold 34.2% of NovaBridge Biosciences's shares outstanding; insiders hold 14.28%.
Which funds own NovaBridge Biosciences?
The largest fund holders of NovaBridge Biosciences are Belfius Equities Cure C Cap (0.98%), iShares Biotechnology ETF (0.56%), E Fund Global Medi Inds Allc QDII CNY A (0.51%), OAKS Emerg and Frntr Opp A EUR Acc Ser 4 (0.27%), State Street® SPDR® Portfolio EM ETF (0.26%).
What is NovaBridge Biosciences's short interest?
3.3M shares of NovaBridge Biosciences were sold short, 6.27% of the float; at the average daily volume it would take 5.62 days to cover.
How many shares of NovaBridge Biosciences are outstanding?
NovaBridge Biosciences has 116.0M shares outstanding, of which 64.4M are in the public float.